InvestorsHub Logo
Followers 37
Posts 7064
Boards Moderated 1
Alias Born 09/06/2014

Re: guardiangel post# 29102

Saturday, 04/18/2015 11:09:13 AM

Saturday, April 18, 2015 11:09:13 AM

Post# of 30046
If DR-70 is "the catalyst for the 2010LOI provista Diagnostics and radient reverse merger" then the merger is definitely dead.

Because DR-70 is off patent. If Provista wants to use DR-70 the can do so without any involvement with Radient.

Remember that Radient declared itself insolvent. That word "insolvent" is not an ambiguous word. It means Radient had debts and obligations it was unable to repay.

To resurrect Radient, an entity would have to pay off that debt and also pay a few hundred thousand more to have auditors create and file the missing SEC financial filings. There is no reason for any entity - Provista or otherwise - to do that when they can get DR-70 much cheaper from UNI or GCDx or the Aussies.

GCDx already has DR-70. If Provista wanted DR-70 they could easily get it from GCDx - aren't they in the same town? Don't they share lab space? It is absurd to suggest that Provista would spend ANY money resurrecting Radient to get DR-70.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.